Mark W Hahn - Net Worth and Insider Trading
Mark W Hahn Net Worth
The estimated net worth of Mark W Hahn is at least $1.3 Billion dollars as of 2026-08-11. Mark W Hahn is the CFO of Verona Pharma PLC and owns about 12,464,968 shares of Verona Pharma PLC (VRNA) stock worth over $1.3 Billion. Mark W Hahn is also the CFO of Dova Pharmaceuticals Inc and owns about 9,024 shares of Dova Pharmaceuticals Inc (DOVA) stock worth over $253,033. Details can be seen in Mark W Hahn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark W Hahn has not made any transactions after 2025-08-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark W Hahn
Mark W Hahn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark W Hahn owns 3 companies in total, including Verona Pharma PLC (VRNA) , ALSP Orchid Acquisition Corp I (ALOR) , and Soleno Therapeutics Inc (SLNO) .
Click here to see the complete history of Mark W Hahn’s form 4 insider trades.
Insider Ownership Summary of Mark W Hahn
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| VRNA | Verona Pharma PLC | 2025-08-01 | Chief Financial Officer |
| ALOR | ALSP Orchid Acquisition Corp I | 2021-11-18 | director |
| SLNO | Soleno Therapeutics Inc | 2025-10-13 | director |
Mark W Hahn Latest Holdings Summary
Mark W Hahn currently owns a total of 2 stocks. Among these stocks, Mark W Hahn owns 12,464,968 shares of Verona Pharma PLC (VRNA) as of August 1, 2025, with a value of $1.3 Billion and a weighting of 99.98%. Mark W Hahn also owns 9,024 shares of Dova Pharmaceuticals Inc (DOVA) as of September 30, 2019, with a value of $253,033 and a weighting of 0.02%.
Latest Holdings of Mark W Hahn
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRNA | Verona Pharma PLC | 2025-08-01 | 12,464,968 | 106.91 | 1,332,629,729 |
| DOVA | Dova Pharmaceuticals Inc | 2019-09-30 | 9,024 | 28.04 | 253,033 |
Holding Weightings of Mark W Hahn
Mark W Hahn Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark W Hahn has made a total of 25 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 0 buys and 25 sells. The most-recent trade in Verona Pharma PLC is the sale of 208,912 shares on August 1, 2025, which brought Mark W Hahn around $3 Million.
According to the SEC Form 4 filings, Mark W Hahn has made a total of 0 transactions in Dova Pharmaceuticals Inc (DOVA) over the past 5 years. The most-recent trade in Dova Pharmaceuticals Inc is the sale of 775 shares on September 30, 2019, which brought Mark W Hahn around $21,700.
Insider Trading History of Mark W Hahn
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Mark W Hahn Trading Performance
GuruFocus tracks the stock performance after each of Mark W Hahn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark W Hahn is 52.55%. GuruFocus also compares Mark W Hahn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark W Hahn within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark W Hahn's insider trading performs compared to the benchmark.
Performance of Mark W Hahn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 35.58 |  | | | | |
| Relative Return to S&P 500(%) | 29.05 | | | | | |
Mark W Hahn Ownership Network
Ownership Network List of Mark W Hahn
Ownership Network Relation of Mark W Hahn
Mark W Hahn Owned Company Details
What does Verona Pharma PLC do?
Who are the key executives at Verona Pharma PLC?
Mark W Hahn is the Chief Financial Officer of Verona Pharma PLC. Other key executives at Verona Pharma PLC include General Counsel Andrew Fisher , Chief Medical Officer Kathleen A. Rickard , and director & President and CEO David Zaccardelli .
Verona Pharma PLC (VRNA) Insider Trades Summary
Over the past 18 months, Mark W Hahn made 5 insider transaction in Verona Pharma PLC (VRNA) with a net sale of 1,686,280. Other recent insider transactions involving Verona Pharma PLC (VRNA) include a net sale of 1,686,280 shares made by David Zaccardelli , a net sale of 336,168 shares made by Kathleen A. Rickard , and a net sale of 344,328 shares made by Vikas Sinha .
In summary, during the past 3 months, insiders sold 0 shares of Verona Pharma PLC (VRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,339,224 shares of Verona Pharma PLC (VRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,339,224 shares.
Verona Pharma PLC (VRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verona Pharma PLC Insider Transactions
Mark W Hahn Mailing Address
Above is the net worth, insider trading, and ownership report for Mark W Hahn. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark W Hahn's mailing address is: Chapel Hill Nc 27517.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
